Top Markets
Coin of the day
Choksi Laboratories Limited Choksi Laboratories Limited

Choksi Laboratories Limited

CHOKSILA
Pozycja w akcjach #32478
Choksi Laboratories Limited provides contract testing and analytical services... Choksi Laboratories Limited provides contract testing and analytical services in India and internationally. Its contract laboratory services include pharmaceutical, food and beverages, soil and water, chemical, and construction material analysis. The company's instrument calibration and validation services comprise laboratory and on-site calibration for test equipment, process equipment, and various end-user equipment; plant shutdown calibration; and consultancy for setting up an in-house calibration laboratory. It also offers environment management, laboratory set-up and management, waste water management, and air pollution monitoring services. In addition, the company provides clinical research services, such as bio-availability and bio-equivalence studies; and consultancy and allied services consisting of training, third-party inspection, and auditing. Further, it offers assaying and hallmarking services for gold and silver. The company serves the pharmaceuticals, consumer products, and engineering sectors. Choksi Laboratories Limited was founded in 1982 and is based in Indore, India.
Cena akcji
$1.43
Kapitalizacja rynkowa
$9.99M
Zmiana (1 dzień)
4.97%
Zmiana (1 rok)
-41.14%
Kraj
IN
Handel Choksi Laboratories Limited (CHOKSILA)

Kategoria

Zyski dla Choksi Laboratories Limited (CHOKSILA)
Zyski w 2026 TTM: 0
Według najnowszych raportów finansowych Choksi Laboratories Limited, obecny zysk firmy wynosi 0. W roku 2026 firma osiągnęła zysk w wysokości 0, równa się zysku z roku 2026, który wynosił 0. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Choksi Laboratories Limited od 2026 do 2026
Zyski na koniec każdego roku
Rok Zyski Zmień
Za mało danych dla podanych dat.
Zyski podobnych firm lub konkurentów
Firma Zyski Różnica w zyskach Kraj
$2.51B -
US
- -
CA
$1.91B -
US
$1.33B -
AU
$517.21M -
US